Citation Tools

Download PDFPDF
Women's Health Initiative randomised ontrolled trial
Combined estrogen plus progestin may reduce coronary heart disease risk after 5 years of use in postmenopausal women starting treatment within 10 years of menopause

Download to a citation manager

Cite this article as:
Harman SM
Combined estrogen plus progestin may reduce coronary heart disease risk after 5 years of use in postmenopausal women starting treatment within 10 years of menopause